PH22011000489U3 - Solid pharmaceutical herbal compositions - Google Patents

Solid pharmaceutical herbal compositions

Info

Publication number
PH22011000489U3
PH22011000489U3 PH2/2011/000489U PH22011000489U PH22011000489U3 PH 22011000489 U3 PH22011000489 U3 PH 22011000489U3 PH 22011000489 U PH22011000489 U PH 22011000489U PH 22011000489 U3 PH22011000489 U3 PH 22011000489U3
Authority
PH
Philippines
Prior art keywords
solid pharmaceutical
herbal compositions
compositions
utility
model
Prior art date
Application number
PH2/2011/000489U
Other versions
PH22011000489U1 (en
Inventor
F Saret Guillermo Jr
Augusto G Pascual Jose
Reginald C Alto Philip
Original Assignee
Pascual Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pascual Laboratories Inc filed Critical Pascual Laboratories Inc
Priority to PH2/2011/000489U priority Critical patent/PH22011000489U3/en
Publication of PH22011000489U1 publication Critical patent/PH22011000489U1/en
Publication of PH22011000489U3 publication Critical patent/PH22011000489U3/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

This utility model is directed to herbal pharmaceutical compositions for oral administration which are safe and effective for the treatment of cough and other related respiratory disorders. In particular, this utility model provides solid pharmaceutical compositions comprising Vitex negundo, locally known as lagundi, as the main active component and other pharmaceutically acceptable additives. The described solid pharmaceutical herbal compositions may either be in the form of tablets or capsules.
PH2/2011/000489U 2011-10-03 2011-10-03 Solid pharmaceutical herbal compositions PH22011000489U3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH2/2011/000489U PH22011000489U3 (en) 2011-10-03 2011-10-03 Solid pharmaceutical herbal compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH2/2011/000489U PH22011000489U3 (en) 2011-10-03 2011-10-03 Solid pharmaceutical herbal compositions

Publications (2)

Publication Number Publication Date
PH22011000489U1 PH22011000489U1 (en) 2012-05-28
PH22011000489U3 true PH22011000489U3 (en) 2012-08-28

Family

ID=95023003

Family Applications (1)

Application Number Title Priority Date Filing Date
PH2/2011/000489U PH22011000489U3 (en) 2011-10-03 2011-10-03 Solid pharmaceutical herbal compositions

Country Status (1)

Country Link
PH (1) PH22011000489U3 (en)

Also Published As

Publication number Publication date
PH22011000489U1 (en) 2012-05-28

Similar Documents

Publication Publication Date Title
IN2014DN09434A (en)
UA115139C2 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2013158680A3 (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
TN2011000536A1 (en) A novel formulation of naproxen
PH12016500746B1 (en) A novel formulation of meloxicam
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
IN2014MN02269A (en)
WO2013147649A3 (en) Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases
TN2015000135A1 (en) Modified release formulations for oprozomib
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX390695B (en) Antidiabetic solid pharmaceutical compositions
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
HK1225972A1 (en) Use of laquinimod to delay huntington's disease progression
BR112014004737A2 (en) Ambroxol Hydrochloride Compound Compound and Method of Preparation of Compound
CA2863829A1 (en) Oral unit dosage forms and uses of same for the treatment of gaucher disease
IN2014MN01933A (en)
PH12013500980A1 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
WO2013038200A3 (en) Neurodevelopmental disorders
PH22011000489U3 (en) Solid pharmaceutical herbal compositions
PH22011000655U1 (en) Pharmaceutical herbal composition
WO2011139414A3 (en) Dexlansoprazole polymorphic forms
WO2011093814A3 (en) A pharmaceutical combination comprising formoterol and ciclesonide
WO2011093810A3 (en) Dry powder pharmaceutical composition comprising tiotropium and mometasone